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Abstract 
Background: Polymicrobial keratitis with fungus and bacteria can lead to blindness and is challenging to treat. Here, 
we introduce a case of fungal keratitis caused by two different strains in addition to definite bacterial super-infection 
caused by an α-Streptococcus sp., and describe the importance of microscopic examination.
Case presentation: A 74-year-old woman, who had a past history of infection with leprosy, presented with conjunc-
tival hyperaemia, pain, and corneal opacity in her right eye. Under the presumptive diagnosis of infectious keratitis, 
corneal scrapings were stained by various reagents and inoculated on several agar plates. Microscopic findings of the 
scrapings revealed fungi and a small number of Gram-positive cocci. Multiple anti-fungal therapies with levofloxacin 
ophthalmic solution were administered. Although empiric treatment was initially effective, keratitis recurred 10 days 
after its initiation. Repeated corneal scraping revealed an abundance of Gram-positive chain cocci and a small amount 
of fungi, resulting in the switching of an antibiotic medication from levofloxacin to moxifloxacin and cefmenoxime. 
Keratitis resolved gradually after the conversion. Stemphylium sp., Acremonium sp., and α-Streptococcus sp. were simul-
taneously isolated from the corneal scrapings.
Conclusions: To the best of our knowledge, this is the first case of fungal keratitis caused by Stemphylium sp., and 
also the first case of super-infection in the cornea caused by two different fungi and one bacterium. Microscopic 
examination of the corneal scrapings was beneficial in rapid decision of changing to appropriate drug according to 
the dominancy of pathogenicity.
Keywords: Keratitis, Super-infection, Stemphylium, Acremonium, α-Streptococcus, Microscopic examination, 
Pathogenicity
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Fungal eye infection is a refractory infectious disease that 
can lead to blindness [1]. Since the cultivation of fungi 
generally takes longer than that of bacteria [2], clinicians 
should diagnose fungal infection through cornea micro-
scopic examination of clinical samples as soon as pos-
sible. In ophthalmology, the clinical diagnosis of fungal 
keratitis can easily be established when fungi are pre-
sent in the corneal smear. Since mixed infections with a 
combination of bacteria and fungus are not uncommon 
[3], it is reasonable for ophthalmologists to administer 
topical antibiotics eye drops as an adjunctive therapy for 
prophylaxis of bacterial super infection, even in cases of 
microscopically proved fungal keratitis. The selection 
of antibiotics in such cases is generally not rigorous but 
empirical, and monotherapy with fluoroquinolone eye 
drops may be selected [4, 5]. The selection among qui-
nolones may be regarded as unimportant because an 
antibiotic effect is not the main purpose.
Verifications of the treatment strategy and selection 
of antibiotics are needed if the infection does not heal 
as expected. In such situations, repeated microscopic 
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examination of the clinical samples is useful for the rig-
orous detection of the causative microbes. However, in 
recent ophthalmological clinical settings, corneal scrap-
ing and Gram staining are sometimes avoided, especially 
among non-corneal specialists [6]. Since polymicrobial 
keratitis with fungus and bacteria is not uncommon and 
challenging to treat [7], ophthalmologists should scrape 
the cornea and stain it with Gram reagent.
In this case report, we describe the importance of 
microscopic examination, in terms of both detecting a 
change in pathogenicity dominance and antibiotic selec-
tion, by introducing the first known case of fungal kerati-
tis caused by two different strains plus a definite bacterial 
super-infection caused by α-Streptococcus sp.
Case presentation
A 74-year-old woman, who had visited the clinic regu-
larly due to eye complications caused by leprosy, returned 
irregularly with eye pain and conjunctival hyperaemia in 
her right eye. She had lagophthalmos due to facial palsy. 
During her scheduled visits, she had occasionally been 
prescribed topical steroid for iritis. Slit lamp examination 
revealed infiltration and a white abscess in her temporal 
cornea (Fig. 1a). The corneal scrapings stained by Gram, 
Giemsa, and fungi flora Y reagents, showed a large abun-
dance of fungi and very few Gram-positive cocci (Fig. 2a), 
led us to the diagnosis of fungal keratitis. The corneal 
scrapings were also inoculated on Sabouraud, potato 
dextrose, and sheep blood agar plates (Nissui Pharma-
ceutical Co., Ltd., Tokyo, Japan), and cultivated at both 
room temperature and at 35 °C.
Based on our presumption that Gram-positive cocci 
represented the commensal bacteria of the ocular sur-
face, empirical therapy for fungal infection with 1.0% 
topical voriconazole eye drops (Vfend®, Pfizer Japan Inc., 
Tokyo, Japan), administered every hour and 1.0% pima-
ricin ointment (Pimaricin ophthalmic ointment Senju®, 
Senju Pharmaceutical Co., Ltd., Osaka, Japan), admin-
istered 4 times daily, concurrent with 100  mg/day itra-
conazole (Itrizole® Capsules 50, Janssen Pharmaceutical 
K.K., Tokyo, Japan) were initiated. We also administered 
levofloxacin (LVFX) ophthalmic solution (Cravits® oph-
thalmic solution 1.5%, Santen Pharmaceutical Co., Ltd., 
Osaka, Japan) 4 times daily for the potential occurrence 
of bacterial super infection. Although clinical findings 
improved steadily over the first 5 days, keratitis and ante-
rior chamber inflammation recurred 10  days after ther-
apy initiation. We repeated cornea scraping and staining 
using the same reagents as previously. Microscopic 
images revealed a large number of Gram-positive chain 
cocci (Fig.  2b). Therefore, levofloxacin ophthalmic solu-
tion was replaced by moxifloxacin (MFLX) (Vegamox® 
Fig. 1 Anterior segments photographs at the initial visit. The white 
abscess in the temporal inferior cornea is remarkable (white arrow)
Fig. 2 a Gram staining of the corneal scrapings at first visit (×1000). 
Fungi and a small number of Gram-positive cocci (black arrows) are 
present. b Gram staining of the corneal scrapings at the time of 
relapsing (×1000); there is an abundance of Gram-positive chain 
cocci present
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ophthalmic solution 0.5%, Alcon Japan Ltd., Tokyo, 
Japan) and cefmenoxime (CMX; Bestron® for ophthal-
mic 0.5%, Senju Pharmaceutical Co., Ltd., Osaka, Japan), 
whilst continuing the same antifungal medications.
Cultivation of corneal scrapings before therapy ini-
tiation on Sabouraud and potato dextrose agar plates at 
room temperature resulted in the growth of two differ-
ent fungi 10 days later. At the same time, the cultivation 
on sheep blood agar plate in 35  °C produced bacterial 
colonies 3 days later. One of the two isolates had solitary, 
darkly pigmented, terminal and multicellular conidia 
(dictyoconidia), formed on a distinctive conidiophore 
with a darker terminal swelling (Fig. 3a) and the another 
isolate had hyphae and long ellipsoidal conidia, aggre-
gated in slimy heads at the apex of each phialide (Fig. 3b). 
The sequences of the internal transcribed spacer region 
of ribosomal RNA gene were analyzed by the BLAST 
research at the NCBI website (http://blast.ncbi.nlm.nih.
gov/Blast.cgi). As a result, they showed 100% homology 
with sequence data of Stemphylium spp. strains in the 
former and Acremonium spp. strains in the later. There-
fore, these two isolates were identified as Stemphylium 
spp. and Acremonium spp. based on their morphology 
and phylogeny. The minimum inhibitory concentrations 
(MICs) of several antifungal drugs and minimal effec-
tive concentration of micafungin for the two strains 
were determined by the broth dilution method accord-
ing to M38-A2 of the Clinical and Laboratory Stand-
ards Institute (Table  1). A bacterium was identified as 
α-Streptococcus sp. and the drug sensitivity (Table  2) of 
the strain was determined by an automatic rapid identi-
fication machine (RAISUS, Nissui Pharmaceutical Co., 
Ltd., Tokyo, Japan). Keratitis resolved gradually after 
the conversion of topical antibiotic medications and 
had healed completely 3  months after the conversion 
(Fig. 1b).
Conclusions
The current case highlights rare and important issues 
in the field of infectious diseases; (1) a super infection 
caused by two different fungi and a bacterium, and (2) 
microscopic examination of corneal scrapings can reveal 
changes in the pathogenic superiority. With respect to 
the former issue, rigorous cultivation of corneal scrapings 
and fungal species identification contributed to the cur-
rent report of the first known (to the best our knowledge) 
case of keratitis caused by a Stemphylium sp. This genus 
comprises plant-pathogenic fungi and is widely distrib-
uted globally [8]. Although there are no reports describ-
ing its pathogenicity to humans, we presume that this 
strain of Stemphylium was transferred from an outdoor 
environment to the patient’s cornea because the patient 
lived on a solitary island in a rural area in Japan. Alter-
natively, this strain of Stemphylium may have attached to 
the immune-compromised ocular surface due to keratitis 
Fig. 3 a Slide culture of the isolate of Stemphylium sp. (×400, Lac-
tophenol staining). Conidia form a distinctive conidiophore. b Slide 
culture of the isolate of Acremonium sp. (×400, Lactophenol cotton 
blue staining). Long ellipsoidal conidia are shown
Table 1 Minimum inhibitory concentrations or minimal 
effective concentrations of 2 fungal strains
MCFG micafungin, AMPH amphotericin B, 5-FC flucytosine, FLCZ fluconazole, ITCZ 
itraconazole, VRCZ voriconazole, MCZ miconazole, − not examined because the 
number of spores required for the measurement could not be obtained
Drugs Stemphylium sp. Acremonium sp.
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caused by Acremonium spp. Furthermore, the current 
case had a history of leprosy, which can have several 
sequelae resulting in an immunocompromised condi-
tion at the ocular surface, such as a decrease in corneal 
sensitivity [9] and lagophthalmos [10]. These may have 
affected the polymicrobial keratitis in the current case. 
We believe that rigorous cultivation of the corneal scrap-
ings and species identification of isolated fungi may have 
contributed the discovery of this new keratitis pathogen.
In general, it is difficult for ophthalmologists to detect 
changes in pathogenic superiority in corneal super-infec-
tions by routine examination and clinical course reviews. 
In cases of intractable fungal keratitis, for which empiri-
cal therapy is ineffective, several possibilities should be 
considered: (1) fungal infection has persisted or recurred, 
(2) bacterial super-infection has occurred and the selec-
tion of the antibiotics was inadequate, (3) systemic dis-
eases have caused an immunocompromised ocular 
surface that can affect the clinical course of keratitis, and 
(4) the patient drug adherence was poor. We ruled out (3) 
and (4) as causes, because no history of systemic disease 
that could cause an immunocompromised condition at 
the ocular surface was reported and we confirmed the 
patient’s good adherence to the eye drops. In case of (1), 
the selection of antifungal drugs should be reconsidered 
after rigorous cultivation of pathogenic fungi. In the case 
of (2), the selection of antibiotics should be reconsidered. 
However, it may be difficult to presume that only the con-
version of antibiotics selection leads to keratitis healing, 
in cases initially determined as fungal keratitis. In such 
cases, microscopic examination of the scraped cornea 
is crucial. In the current case, we had to presume that a 
small number of Gram-positive cocci in the first corneal 
scraping represented the pathogenic strain. Despite their 
low numbers, microbes revealed under light microscopy 
should be considered as the possible pathogenic strain 
because they could present in human tissue to a greater 
extent than in the specimen.
MFLX is one of the fourth-generation fluoroqui-
nolone agents, which have increased potency against 
Gram-positive bacteria compared with LVFX [11]. The 
MIC of MFLX for the strain of α-Streptococcus sp. was 
not determined in the current case because the MFLX 
sensitivity test plate was not prepared. However, MFLX 
is more effective at treating infections caused by Strep-
tococcus spp. than LVFX. Gatifloxacin (GFLX), another 
fourth-generation fluoroquinolone agent is thought to be 
more effective for prophylaxis against clinical isolates of 
Streptococcus pneumonia based on a rabbit LASIK model 
[12]. In the current case, we considered potential bacte-
rial invasion into the anterior chamber. Given that MFLX 
has a higher permeability in the anterior chamber than 
GFLX [13], it was reasonable to select MFLX ophthalmic 
solutions, as opposed to GFLX. We also selected CMX, 
a third-generation cephalosporin antibiotic, as an addi-
tional topical medication to MFLX. This was because it 
is generally sensitive to Streptococcus spp. according to 
MIC, and dual-fortified broad-spectrum antibiotics are 
recommended for more severe corneal ulcers [4, 5]. This 
is an inference because we could not test the susceptibili-
ties of MFLX, GFLX, and CMX because the pathogenic 
strain was not sub-cultured and the hospital did not 
prepare MIC measuring plates for these drugs. How-
ever, we believe that the conversion of topical antibiot-
ics from LVFX to MFLX with CMX, dependent on the 
microscopic findings, may have contributed to keratitis 
improvement in the current case.
In conclusion, to the best of our knowledge, this is the 
first case of fungal keratitis caused by a Stemphylium sp. 
It is also the first case of a super-infection in the cornea 
caused by two different fungi with one bacterium. This 
case demonstrates the significance of cornea microscopic 
examinations in infectious keratitis, in terms of rigorous 
diagnosis and detecting changes in pathogenicity domi-
nance. This case substantiates the view that clinicians in 
all fields should perform microscopic examinations for 
intractable infectious cases.
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